APO Research
Talk to an analyst

APO RESEARCH · REPORT

Spasmolytic Injections

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Spasmolytic Injections Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

30 December 2025193 pages

Choose your research edition.

Industry ResearchSpasmolytic Injections Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Spasmolytic Injections Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Spasmolytic Injections Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Spasmolytic Injections Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Spasmolytic Injections Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Spasmolytic Injections market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Spasmolytic Injections is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Spasmolytic Injections is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Spasmolytic Injections is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Spasmolytic Injections is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Spasmolytic Injections include AdvaCare Pharma, Allergan, Baxter International, Boehringer Ingelheim, Chengdu Better Pharmaceutical, CNS Therapeutics, Huarun Shuanghe, Ipsen and Medytox, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Spasmolytic Injections market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Spasmolytic Injections and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Spasmolytic Injections revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Spasmolytic Injections market size, projected growth trends, production technologies, key applications, and end-use industries.

Spasmolytic Injections Segment by Company

AdvaCare Pharma

Allergan

Baxter International

Boehringer Ingelheim

Chengdu Better Pharmaceutical

CNS Therapeutics

Huarun Shuanghe

Ipsen

Medytox

Nanjing Hangsheng Pharmaceutical

Sun Pharmaceutical Industries

Wanbangde Pharmaceutical Group

Wuhan Renfu Pharmaceutical

Zydus Cadila

Lilly

Mylan

Sanofi

Teva Pharmaceuticals

Spasmolytic Injections Segment by Type

Papaverines

Anticholinergics

Calcium Channel Blockers

Others

Spasmolytic Injections Segment by Application

Hospital

Clinic

Spasmolytic Injections Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Spasmolytic Injections market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Spasmolytic Injections and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Spasmolytic Injections.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Spasmolytic Injections in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Spasmolytic Injections industry.

Chapter 3: Detailed analysis of Spasmolytic Injections companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Spasmolytic Injectionsrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Spasmolytic Injections Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Papaverines Table 3. Key Players of Anticholinergics Table 4. Key Players of Calcium Channel Blockers Table 3. Key Players of Others Table 4. Global Spasmolytic Injections Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hospital Table 6. Key Players of Clinic Table 7. Global Spasmolytic Injections Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 8. Global Spasmolytic Injections Market Size by Region (2021-2026) & (US$ Million) Table 9. Global Spasmolytic Injections Market Share by Region (2021-2026) Table 10. Global Spasmolytic Injections Market Size by Region (2027-2032) & (US$ Million) Table 11. Global Spasmolytic Injections Market Share by Region (2027-2032) Table 12. Spasmolytic Injections Industry Trends Table 13. Spasmolytic Injections Industry Drivers Table 14. Spasmolytic Injections Industry Opportunities and Challenges Table 15. Spasmolytic Injections Industry Restraints Table 16. Global Spasmolytic Injections Revenue by Company (US$ Million) & (2021-2026) Table 17. Global Spasmolytic Injections Revenue Market Share by Company (2021-2026) Table 18. Global Spasmolytic Injections Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 19. Global Spasmolytic Injections Key Company Head Office and Area Served Table 20. Global Spasmolytic Injections Company, Product Type & Application Table 21. Global Spasmolytic Injections Company Establishment Date Table 22. Global Company Market Concentration Ratio (CR5 and HHI) Table 23. Global Spasmolytic Injections by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 24. Global Spasmolytic Injections Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Spasmolytic Injections Market Size by Type (2021-2026) & (US$ Million) Table 26. Global Spasmolytic Injections Market Size by Type (2027-2032) & (US$ Million) Table 27. Global Spasmolytic Injections Revenue Market Share by Type (2021-2026) Table 28. Global Spasmolytic Injections Revenue Market Share by Type (2027-2032) Table 29. Global Spasmolytic Injections Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Spasmolytic Injections Market Size by Application (2021-2026) & (US$ Million) Table 31. Global Spasmolytic Injections Market Size by Application (2027-2032) & (US$ Million) Table 32. Global Spasmolytic Injections Revenue Market Share by Application (2021-2026) Table 33. Global Spasmolytic Injections Revenue Market Share by Application (2027-2032) Table 34. AdvaCare Pharma Company Information Table 35. AdvaCare Pharma Business Overview Table 36. AdvaCare Pharma Spasmolytic Injections Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. AdvaCare Pharma Spasmolytic Injections Product Portfolio Table 38. AdvaCare Pharma Recent Development Table 39. Allergan Company Information Table 40. Allergan Business Overview Table 41. Allergan Spasmolytic Injections Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Allergan Spasmolytic Injections Product Portfolio Table 43. Allergan Recent Development Table 44. Baxter International Company Information Table 45. Baxter International Business Overview Table 46. Baxter International Spasmolytic Injections Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Baxter International Spasmolytic Injections Product Portfolio Table 48. Baxter International Recent Development Table 49. Boehringer Ingelheim Company Information Table 50. Boehringer Ingelheim Business Overview Table 51. Boehringer Ingelheim Spasmolytic Injections Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Boehringer Ingelheim Spasmolytic Injections Product Portfolio Table 53. Boehringer Ingelheim Recent Development Table 54. Chengdu Better Pharmaceutical Company Information Table 55. Chengdu Better Pharmaceutical Business Overview Table 56. Chengdu Better Pharmaceutical Spasmolytic Injections Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Chengdu Better Pharmaceutical Spasmolytic Injections Product Portfolio Table 58. Chengdu Better Pharmaceutical Recent Development Table 59. CNS Therapeutics Company Information Table 60. CNS Therapeutics Business Overview Table 61. CNS Therapeutics Spasmolytic Injections Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. CNS Therapeutics Spasmolytic Injections Product Portfolio Table 63. CNS Therapeutics Recent Development Table 64. Huarun Shuanghe Company Information Table 65. Huarun Shuanghe Business Overview Table 66. Huarun Shuanghe Spasmolytic Injections Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Huarun Shuanghe Spasmolytic Injections Product Portfolio Table 68. Huarun Shuanghe Recent Development Table 69. Ipsen Company Information Table 70. Ipsen Business Overview Table 71. Ipsen Spasmolytic Injections Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Ipsen Spasmolytic Injections Product Portfolio Table 73. Ipsen Recent Development Table 74. Medytox Company Information Table 75. Medytox Business Overview Table 76. Medytox Spasmolytic Injections Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Medytox Spasmolytic Injections Product Portfolio Table 78. Medytox Recent Development Table 79. Nanjing Hangsheng Pharmaceutical Company Information Table 80. Nanjing Hangsheng Pharmaceutical Business Overview Table 81. Nanjing Hangsheng Pharmaceutical Spasmolytic Injections Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Nanjing Hangsheng Pharmaceutical Spasmolytic Injections Product Portfolio Table 83. Nanjing Hangsheng Pharmaceutical Recent Development Table 84. Sun Pharmaceutical Industries Company Information Table 85. Sun Pharmaceutical Industries Business Overview Table 86. Sun Pharmaceutical Industries Spasmolytic Injections Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. Sun Pharmaceutical Industries Spasmolytic Injections Product Portfolio Table 88. Sun Pharmaceutical Industries Recent Development Table 89. Wanbangde Pharmaceutical Group Company Information Table 90. Wanbangde Pharmaceutical Group Business Overview Table 91. Wanbangde Pharmaceutical Group Spasmolytic Injections Revenue and Gross Margin (US$ Million) & (2021-2026) Table 92. Wanbangde Pharmaceutical Group Spasmolytic Injections Product Portfolio Table 93. Wanbangde Pharmaceutical Group Recent Development Table 94. Wuhan Renfu Pharmaceutical Company Information Table 95. Wuhan Renfu Pharmaceutical Business Overview Table 96. Wuhan Renfu Pharmaceutical Spasmolytic Injections Revenue and Gross Margin (US$ Million) & (2021-2026) Table 97. Wuhan Renfu Pharmaceutical Spasmolytic Injections Product Portfolio Table 98. Wuhan Renfu Pharmaceutical Recent Development Table 99. Zydus Cadila Company Information Table 100. Zydus Cadila Business Overview Table 101. Zydus Cadila Spasmolytic Injections Revenue and Gross Margin (US$ Million) & (2021-2026) Table 102. Zydus Cadila Spasmolytic Injections Product Portfolio Table 103. Zydus Cadila Recent Development Table 104. Lilly Company Information Table 105. Lilly Business Overview Table 106. Lilly Spasmolytic Injections Revenue and Gross Margin (US$ Million) & (2021-2026) Table 107. Lilly Spasmolytic Injections Product Portfolio Table 108. Lilly Recent Development Table 109. Mylan Company Information Table 110. Mylan Business Overview Table 111. Mylan Spasmolytic Injections Revenue and Gross Margin (US$ Million) & (2021-2026) Table 112. Mylan Spasmolytic Injections Product Portfolio Table 113. Mylan Recent Development Table 114. Sanofi Company Information Table 115. Sanofi Business Overview Table 116. Sanofi Spasmolytic Injections Revenue and Gross Margin (US$ Million) & (2021-2026) Table 117. Sanofi Spasmolytic Injections Product Portfolio Table 118. Sanofi Recent Development Table 119. Teva Pharmaceuticals Company Information Table 120. Teva Pharmaceuticals Business Overview Table 121. Teva Pharmaceuticals Spasmolytic Injections Revenue and Gross Margin (US$ Million) & (2021-2026) Table 122. Teva Pharmaceuticals Spasmolytic Injections Product Portfolio Table 123. Teva Pharmaceuticals Recent Development Table 124. North America Spasmolytic Injections Market Size by Type (2021-2026) & (US$ Million) Table 125. North America Spasmolytic Injections Market Size by Type (2027-2032) & (US$ Million) Table 126. North America Spasmolytic Injections Market Size by Application (2021-2026) & (US$ Million) Table 127. North America Spasmolytic Injections Market Size by Application (2027-2032) & (US$ Million) Table 128. North America Spasmolytic Injections Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 129. North America Spasmolytic Injections Market Size by Country (2021-2026) Table 130. North America Spasmolytic Injections Market Size by Country (2027-2032) Table 131. Europe Spasmolytic Injections Market Size by Type (2021-2026) & (US$ Million) Table 132. Europe Spasmolytic Injections Market Size by Type (2027-2032) & (US$ Million) Table 133. Europe Spasmolytic Injections Market Size by Application (2021-2026) & (US$ Million) Table 134. Europe Spasmolytic Injections Market Size by Application (2027-2032) & (US$ Million) Table 135. Europe Spasmolytic Injections Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 136. Europe Spasmolytic Injections Market Size by Country (2021-2026) Table 137. Europe Spasmolytic Injections Market Size by Country (2027-2032) Table 138. China Spasmolytic Injections Market Size by Type (2021-2026) & (US$ Million) Table 139. China Spasmolytic Injections Market Size by Type (2027-2032) & (US$ Million) Table 140. China Spasmolytic Injections Market Size by Application (2021-2026) & (US$ Million) Table 141. China Spasmolytic Injections Market Size by Application (2027-2032) & (US$ Million) Table 142. Asia Spasmolytic Injections Market Size by Type (2021-2026) & (US$ Million) Table 143. Asia Spasmolytic Injections Market Size by Type (2027-2032) & (US$ Million) Table 144. Asia Spasmolytic Injections Market Size by Application (2021-2026) & (US$ Million) Table 145. Asia Spasmolytic Injections Market Size by Application (2027-2032) & (US$ Million) Table 146. Asia Spasmolytic Injections Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 147. Asia Spasmolytic Injections Market Size by Country (2021-2026) Table 148. Asia Spasmolytic Injections Market Size by Country (2027-2032) Table 149. South America, Middle East & Africa Spasmolytic Injections Market Size by Type (2021-2026) & (US$ Million) Table 150. South America, Middle East & Africa Spasmolytic Injections Market Size by Type (2027-2032) & (US$ Million) Table 151. South America, Middle East & Africa Spasmolytic Injections Market Size by Application (2021-2026) & (US$ Million) Table 152. South America, Middle East & Africa Spasmolytic Injections Market Size by Application (2027-2032) & (US$ Million) Table 153. South America, Middle East & Africa Spasmolytic Injections Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 154. South America, Middle East & Africa Spasmolytic Injections Market Size by Country (2021-2026) Table 155. South America, Middle East & Africa Spasmolytic Injections Market Size by Country (2027-2032) Table 156. Research Programs/Design for This Report Table 157. Authors List of This Report Table 158. Secondary Sources Table 159. Primary Sources List of Figures Figure 1. Spasmolytic Injections Product Image Figure 2. Global Spasmolytic Injections Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Spasmolytic Injections Market Share by Type: 2025 VS 2032 Figure 4. Papaverines Image Figure 5. Anticholinergics Image Figure 6. Calcium Channel Blockers Image Figure 7. Others Image Figure 8. Global Spasmolytic Injections Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Spasmolytic Injections Market Share by Application: 2025 VS 2032 Figure 10. Hospital Image Figure 11. Clinic Image Figure 12. Global Spasmolytic Injections Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Spasmolytic Injections Market Size (2021-2032) & (US$ Million) Figure 14. Global Spasmolytic Injections Market Share by Region: 2025 VS 2032 Figure 15. Years Considered Figure 16. Global Spasmolytic Injections Market Share by Players in 2025 Figure 17. Global Top 5 and 10 Spasmolytic Injections Players Market Share by Revenue in 2025 Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Spasmolytic Injections Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Spasmolytic Injections Revenue Market Share by Type (2021-2032) Figure 21. Global Spasmolytic Injections Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Spasmolytic Injections Revenue Market Share by Application (2021-2032) Figure 23. North America Spasmolytic Injections Market Size (2021-2032) & (US$ Million) Figure 24. North America Spasmolytic Injections Market Share by Type (2021-2032) Figure 25. North America Spasmolytic Injections Market Share by Application (2021-2032) Figure 26. North America Spasmolytic Injections Market Share by Country (2021-2032) Figure 27. United States Spasmolytic Injections Market Size (2021-2032) & (US$ Million) Figure 28. Canada Spasmolytic Injections Market Size (2021-2032) & (US$ Million) Figure 29. Mexico Spasmolytic Injections Market Size (2021-2032) & (US$ Million) Figure 30. Europe Spasmolytic Injections Market Size (2021-2032) & (US$ Million) Figure 31. Europe Spasmolytic Injections Market Share by Type (2021-2032) Figure 32. Europe Spasmolytic Injections Market Share by Application (2021-2032) Figure 33. Europe Spasmolytic Injections Market Share by Country (2021-2032) Figure 34. Germany Spasmolytic Injections Market Size (2021-2032) & (US$ Million) Figure 35. France Spasmolytic Injections Market Size (2021-2032) & (US$ Million) Figure 36. U.K. Spasmolytic Injections Market Size (2021-2032) & (US$ Million) Figure 37. Italy Spasmolytic Injections Market Size (2021-2032) & (US$ Million) Figure 38. Russia Spasmolytic Injections Market Size (2021-2032) & (US$ Million) Figure 39. Nordic Countries Spasmolytic Injections Market Size (2021-2032) & (US$ Million) Figure 40. China Spasmolytic Injections Market Size (2021-2032) & (US$ Million) Figure 41. China Spasmolytic Injections Market Share by Type (2021-2032) Figure 42. China Spasmolytic Injections Market Share by Application (2021-2032) Figure 43. Asia Spasmolytic Injections Market Size (2021-2032) & (US$ Million) Figure 44. Asia Spasmolytic Injections Market Share by Type (2021-2032) Figure 45. Asia Spasmolytic Injections Market Share by Application (2021-2032) Figure 46. Asia Spasmolytic Injections Market Share by Country (2021-2032) Figure 47. Japan Spasmolytic Injections Market Size (2021-2032) & (US$ Million) Figure 48. South Korea Spasmolytic Injections Market Size (2021-2032) & (US$ Million) Figure 49. Taiwan Spasmolytic Injections Market Size (2021-2032) & (US$ Million) Figure 50. Southeast Asia Spasmolytic Injections Market Size (2021-2032) & (US$ Million) Figure 51. India Spasmolytic Injections Market Size (2021-2032) & (US$ Million) Figure 52. Australia Spasmolytic Injections Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Spasmolytic Injections Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Spasmolytic Injections Market Share by Type (2021-2032) Figure 55. South America, Middle East & Africa Spasmolytic Injections Market Share by Application (2021-2032) Figure 56. South America, Middle East & Africa Spasmolytic Injections Market Share by Country (2021-2032) Figure 57. Brazil Spasmolytic Injections Market Size (2021-2032) & (US$ Million) Figure 58. South Africa Spasmolytic Injections Market Size (2021-2032) & (US$ Million) Figure 59. Saudi Arabia Spasmolytic Injections Market Size (2021-2032) & (US$ Million) Figure 60. Turkey Spasmolytic Injections Market Size (2021-2032) & (US$ Million) Figure 61. Argentina Spasmolytic Injections Market Size (2021-2032) & (US$ Million) Figure 62. UAE Spasmolytic Injections Market Size (2021-2032) & (US$ Million) Figure 63. Egypt Spasmolytic Injections Market Size (2021-2032) & (US$ Million) Figure 64. Chile Spasmolytic Injections Market Size (2021-2032) & (US$ Million) Figure 65. Research Process Figure 66. Key Executives Interviewed

Scope & coverage.

Types
  • Papaverines
  • Anticholinergics
  • Calcium Channel Blockers
  • Others
Applications
  • Hospital
  • Clinic
Companies covered
  • AdvaCare Pharma
  • Allergan
  • Baxter International
  • Boehringer Ingelheim
  • Chengdu Better Pharmaceutical
  • CNS Therapeutics
  • Huarun Shuanghe
  • Ipsen
  • Medytox
  • Nanjing Hangsheng Pharmaceutical
  • Sun Pharmaceutical Industries
  • Wanbangde Pharmaceutical Group
  • Wuhan Renfu Pharmaceutical
  • Zydus Cadila
  • Lilly
  • Mylan
  • Sanofi
  • Teva Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Spasmolytic Injections Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Papaverines
  5. 1.2.3 Anticholinergics
  6. 1.2.4 Calcium Channel Blockers
  7. 1.2.5 Others
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Spasmolytic Injections Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Hospital
  11. 1.3.3 Clinic
  12. 1.4 Global Market Growth Prospects
  13. 1.5 Global Spasmolytic Injections Growth Trends by Region
  14. 1.5.1 Global Spasmolytic Injections Market Size by Region: 2021 VS 2025 VS 2032
  15. 1.5.2 Spasmolytic Injections Market Size by Region (2021-2026)
  16. 1.5.3 Spasmolytic Injections Market Size by Region (2027-2032)
  17. 1.6 Assumptions and Limitations
  18. 1.7 Study Goals and Objectives
  19. 1.8 Years Considered
2 Global Spasmolytic Injections Market Dynamics
  1. 2.1 Spasmolytic Injections Industry Trends
  2. 2.2 Spasmolytic Injections Industry Drivers
  3. 2.3 Spasmolytic Injections Industry Opportunities and Challenges
  4. 2.4 Spasmolytic Injections Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Spasmolytic Injections Revenue by Company (2021-2026)
  2. 3.2 Global Spasmolytic Injections Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Spasmolytic Injections Key Company Head office and Area Served
  4. 3.4 Global Spasmolytic Injections Company, Product Type & Application
  5. 3.5 Global Spasmolytic Injections Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Spasmolytic Injections Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Spasmolytic Injections Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Spasmolytic Injections Tier 1, Tier 2, and Tier 3
4 Spasmolytic Injections Market by Type
  1. 4.1 Global Spasmolytic Injections Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Spasmolytic Injections Market Size by Type (2021-2032)
  3. 4.3 Global Spasmolytic Injections Market Size Share by Type (2021-2032)
5 Spasmolytic Injections Market by Application
  1. 5.1 Global Spasmolytic Injections Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Spasmolytic Injections Market Size by Application (2021-2032)
  3. 5.3 Global Spasmolytic Injections Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 AdvaCare Pharma
  2. 6.1.1 AdvaCare Pharma Company Information
  3. 6.1.2 AdvaCare Pharma Business Overview
  4. 6.1.3 AdvaCare Pharma Spasmolytic Injections Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 AdvaCare Pharma Spasmolytic Injections Product Portfolio
  6. 6.1.5 AdvaCare Pharma Recent Developments
  7. 6.2 Allergan
  8. 6.2.1 Allergan Company Information
  9. 6.2.2 Allergan Business Overview
  10. 6.2.3 Allergan Spasmolytic Injections Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Allergan Spasmolytic Injections Product Portfolio
  12. 6.2.5 Allergan Recent Developments
  13. 6.3 Baxter International
  14. 6.3.1 Baxter International Company Information
  15. 6.3.2 Baxter International Business Overview
  16. 6.3.3 Baxter International Spasmolytic Injections Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Baxter International Spasmolytic Injections Product Portfolio
  18. 6.3.5 Baxter International Recent Developments
  19. 6.4 Boehringer Ingelheim
  20. 6.4.1 Boehringer Ingelheim Company Information
  21. 6.4.2 Boehringer Ingelheim Business Overview
  22. 6.4.3 Boehringer Ingelheim Spasmolytic Injections Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Boehringer Ingelheim Spasmolytic Injections Product Portfolio
  24. 6.4.5 Boehringer Ingelheim Recent Developments
  25. 6.5 Chengdu Better Pharmaceutical
  26. 6.5.1 Chengdu Better Pharmaceutical Company Information
  27. 6.5.2 Chengdu Better Pharmaceutical Business Overview
  28. 6.5.3 Chengdu Better Pharmaceutical Spasmolytic Injections Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Chengdu Better Pharmaceutical Spasmolytic Injections Product Portfolio
  30. 6.5.5 Chengdu Better Pharmaceutical Recent Developments
  31. 6.6 CNS Therapeutics
  32. 6.6.1 CNS Therapeutics Company Information
  33. 6.6.2 CNS Therapeutics Business Overview
  34. 6.6.3 CNS Therapeutics Spasmolytic Injections Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 CNS Therapeutics Spasmolytic Injections Product Portfolio
  36. 6.6.5 CNS Therapeutics Recent Developments
  37. 6.7 Huarun Shuanghe
  38. 6.7.1 Huarun Shuanghe Company Information
  39. 6.7.2 Huarun Shuanghe Business Overview
  40. 6.7.3 Huarun Shuanghe Spasmolytic Injections Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Huarun Shuanghe Spasmolytic Injections Product Portfolio
  42. 6.7.5 Huarun Shuanghe Recent Developments
  43. 6.8 Ipsen
  44. 6.8.1 Ipsen Company Information
  45. 6.8.2 Ipsen Business Overview
  46. 6.8.3 Ipsen Spasmolytic Injections Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Ipsen Spasmolytic Injections Product Portfolio
  48. 6.8.5 Ipsen Recent Developments
  49. 6.9 Medytox
  50. 6.9.1 Medytox Company Information
  51. 6.9.2 Medytox Business Overview
  52. 6.9.3 Medytox Spasmolytic Injections Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Medytox Spasmolytic Injections Product Portfolio
  54. 6.9.5 Medytox Recent Developments
  55. 6.10 Nanjing Hangsheng Pharmaceutical
  56. 6.10.1 Nanjing Hangsheng Pharmaceutical Company Information
  57. 6.10.2 Nanjing Hangsheng Pharmaceutical Business Overview
  58. 6.10.3 Nanjing Hangsheng Pharmaceutical Spasmolytic Injections Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Nanjing Hangsheng Pharmaceutical Spasmolytic Injections Product Portfolio
  60. 6.10.5 Nanjing Hangsheng Pharmaceutical Recent Developments
  61. 6.11 Sun Pharmaceutical Industries
  62. 6.11.1 Sun Pharmaceutical Industries Company Information
  63. 6.11.2 Sun Pharmaceutical Industries Business Overview
  64. 6.11.3 Sun Pharmaceutical Industries Spasmolytic Injections Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Sun Pharmaceutical Industries Spasmolytic Injections Product Portfolio
  66. 6.11.5 Sun Pharmaceutical Industries Recent Developments
  67. 6.12 Wanbangde Pharmaceutical Group
  68. 6.12.1 Wanbangde Pharmaceutical Group Company Information
  69. 6.12.2 Wanbangde Pharmaceutical Group Business Overview
  70. 6.12.3 Wanbangde Pharmaceutical Group Spasmolytic Injections Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Wanbangde Pharmaceutical Group Spasmolytic Injections Product Portfolio
  72. 6.12.5 Wanbangde Pharmaceutical Group Recent Developments
  73. 6.13 Wuhan Renfu Pharmaceutical
  74. 6.13.1 Wuhan Renfu Pharmaceutical Company Information
  75. 6.13.2 Wuhan Renfu Pharmaceutical Business Overview
  76. 6.13.3 Wuhan Renfu Pharmaceutical Spasmolytic Injections Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Wuhan Renfu Pharmaceutical Spasmolytic Injections Product Portfolio
  78. 6.13.5 Wuhan Renfu Pharmaceutical Recent Developments
  79. 6.14 Zydus Cadila
  80. 6.14.1 Zydus Cadila Company Information
  81. 6.14.2 Zydus Cadila Business Overview
  82. 6.14.3 Zydus Cadila Spasmolytic Injections Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Zydus Cadila Spasmolytic Injections Product Portfolio
  84. 6.14.5 Zydus Cadila Recent Developments
  85. 6.15 Lilly
  86. 6.15.1 Lilly Company Information
  87. 6.15.2 Lilly Business Overview
  88. 6.15.3 Lilly Spasmolytic Injections Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Lilly Spasmolytic Injections Product Portfolio
  90. 6.15.5 Lilly Recent Developments
  91. 6.16 Mylan
  92. 6.16.1 Mylan Company Information
  93. 6.16.2 Mylan Business Overview
  94. 6.16.3 Mylan Spasmolytic Injections Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Mylan Spasmolytic Injections Product Portfolio
  96. 6.16.5 Mylan Recent Developments
  97. 6.17 Sanofi
  98. 6.17.1 Sanofi Company Information
  99. 6.17.2 Sanofi Business Overview
  100. 6.17.3 Sanofi Spasmolytic Injections Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 Sanofi Spasmolytic Injections Product Portfolio
  102. 6.17.5 Sanofi Recent Developments
  103. 6.18 Teva Pharmaceuticals
  104. 6.18.1 Teva Pharmaceuticals Company Information
  105. 6.18.2 Teva Pharmaceuticals Business Overview
  106. 6.18.3 Teva Pharmaceuticals Spasmolytic Injections Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 Teva Pharmaceuticals Spasmolytic Injections Product Portfolio
  108. 6.18.5 Teva Pharmaceuticals Recent Developments
7 North America
  1. 7.1 North America Spasmolytic Injections Market Size (2021-2032)
  2. 7.2 North America Spasmolytic Injections Market Size by Type
  3. 7.2.1 North America Spasmolytic Injections Market Size by Type (2021-2026)
  4. 7.2.2 North America Spasmolytic Injections Market Size by Type (2027-2032)
  5. 7.2.3 North America Spasmolytic Injections Market Share by Type (2021-2032)
  6. 7.3 North America Spasmolytic Injections Market Size by Application
  7. 7.3.1 North America Spasmolytic Injections Market Size by Application (2021-2026)
  8. 7.3.2 North America Spasmolytic Injections Market Size by Application (2027-2032)
  9. 7.3.3 North America Spasmolytic Injections Market Share by Application (2021-2032)
  10. 7.4 North America Spasmolytic Injections Market Size by Country
  11. 7.4.1 North America Spasmolytic Injections Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Spasmolytic Injections Market Size by Country (2021-2026)
  13. 7.4.3 North America Spasmolytic Injections Market Size by Country (2027-2032)
  14. 7.4.4 North America Spasmolytic Injections Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Spasmolytic Injections Market Size (2021-2032)
  2. 8.2 Europe Spasmolytic Injections Market Size by Type
  3. 8.2.1 Europe Spasmolytic Injections Market Size by Type (2021-2026)
  4. 8.2.2 Europe Spasmolytic Injections Market Size by Type (2027-2032)
  5. 8.2.3 Europe Spasmolytic Injections Market Share by Type (2021-2032)
  6. 8.3 Europe Spasmolytic Injections Market Size by Application
  7. 8.3.1 Europe Spasmolytic Injections Market Size by Application (2021-2026)
  8. 8.3.2 Europe Spasmolytic Injections Market Size by Application (2027-2032)
  9. 8.3.3 Europe Spasmolytic Injections Market Share by Application (2021-2032)
  10. 8.4 Europe Spasmolytic Injections Market Size by Country
  11. 8.4.1 Europe Spasmolytic Injections Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Spasmolytic Injections Market Size by Country (2021-2026)
  13. 8.4.3 Europe Spasmolytic Injections Market Size by Country (2027-2032)
  14. 8.4.4 Europe Spasmolytic Injections Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Spasmolytic Injections Market Size (2021-2032)
  2. 9.2 China Spasmolytic Injections Market Size by Type
  3. 9.2.1 China Spasmolytic Injections Market Size by Type (2021-2026)
  4. 9.2.2 China Spasmolytic Injections Market Size by Type (2027-2032)
  5. 9.2.3 China Spasmolytic Injections Market Share by Type (2021-2032)
  6. 9.3 China Spasmolytic Injections Market Size by Application
  7. 9.3.1 China Spasmolytic Injections Market Size by Application (2021-2026)
  8. 9.3.2 China Spasmolytic Injections Market Size by Application (2027-2032)
  9. 9.3.3 China Spasmolytic Injections Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Spasmolytic Injections Market Size (2021-2032)
  2. 10.2 Asia Spasmolytic Injections Market Size by Type
  3. 10.2.1 Asia Spasmolytic Injections Market Size by Type (2021-2026)
  4. 10.2.2 Asia Spasmolytic Injections Market Size by Type (2027-2032)
  5. 10.2.3 Asia Spasmolytic Injections Market Share by Type (2021-2032)
  6. 10.3 Asia Spasmolytic Injections Market Size by Application
  7. 10.3.1 Asia Spasmolytic Injections Market Size by Application (2021-2026)
  8. 10.3.2 Asia Spasmolytic Injections Market Size by Application (2027-2032)
  9. 10.3.3 Asia Spasmolytic Injections Market Share by Application (2021-2032)
  10. 10.4 Asia Spasmolytic Injections Market Size by Country
  11. 10.4.1 Asia Spasmolytic Injections Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Spasmolytic Injections Market Size by Country (2021-2026)
  13. 10.4.3 Asia Spasmolytic Injections Market Size by Country (2027-2032)
  14. 10.4.4 Asia Spasmolytic Injections Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Spasmolytic Injections Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Spasmolytic Injections Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Spasmolytic Injections Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Spasmolytic Injections Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Spasmolytic Injections Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Spasmolytic Injections Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Spasmolytic Injections Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Spasmolytic Injections Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Spasmolytic Injections Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Spasmolytic Injections Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Spasmolytic Injections Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Spasmolytic Injections Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Spasmolytic Injections Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Spasmolytic Injections Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst